AgenciesYes Securities has buy call on Strides Pharma Science with a target price of Rs 1050. The current market price of Strides Pharma Science Ltd. is Rs 955.
Strides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 8568.66 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 30-09-2020, the company reported a Consolidated sales of Rs 793.56 Crore, up 1.50 % from last quarter Sales of Rs 781.80 Crore and up 10.97 % from last year same quarter Sales of Rs 715.09 Crore Company reported net profit after tax of Rs 107.11 Crore in latest quarter.
Investment Rationale
Sustained moves above important averages is likely to keep near-term outlook positive.
Promoter/FII Holdings
Promoters held 29.7 per cent stake in the company as of June 30, 2020, while FIIs held 26.8 per cent, DIIs 19.4 per cent and public and others 24.1 per cent.
Strides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 8568.66 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 30-09-2020, the company reported a Consolidated sales of Rs 793.56 Crore, up 1.50 % from last quarter Sales of Rs 781.80 Crore and up 10.97 % from last year same quarter Sales of Rs 715.09 Crore Company reported net profit after tax of Rs 107.11 Crore in latest quarter.
Investment Rationale
Sustained moves above important averages is likely to keep near-term outlook positive.
Promoter/FII Holdings
Promoters held 29.7 per cent stake in the company as of June 30, 2020, while FIIs held 26.8 per cent, DIIs 19.4 per cent and public and others 24.1 per cent.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.